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0929-6646/Copyright ª 2015, ElsevierBackground/Purpose: To assess knowledge improvement by the participants in a pharmacist-
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the educational needs of adults related to medications.
Methods: This was a single-group, pre- and post-program comparative study. From February
2005 to February 2006, 1983 community residents participating in the education program imple-
mented at 57 community universities nationwidewere included. A questionnaire consisting of 50
true/false questions was administered before and after the program to assess the participants’
medication knowledge. Paired t test was used to analyze the pre- and post-program differences
and generalized linear mixed models were applied to examine the demographic variables that
might influence the background knowledge and outcome after adjusting for school effects.
Results: A total of 848 participants (42.8%) completed the pre-to-post questionnaire. Baseline
medication knowledge was positively correlated with participants’ education level andave no conflicts of interest relevant to this article.
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1268 Y.-M. Huang et al.negatively correlated with age. Significant improvement (11.3%, p < 0.001) in medication
knowledge was evident at the end of the program. The age and education level were significant
determinants in the improvement of the pre-to-post program test score. The specific areas that
required improvementmost in the knowledge of the participants were: instructions on refill pre-
scriptions, proper storage of medication, the health insurance system, drug use in special popu-
lations, and over-the-counter drugs.
Conclusion: This national program improved participants’ medication knowledge over a 4-
month period. Patient counseling focusing more on the knowledge deficiency identified in this
study during patient care is recommended.
Copyright ª 2015, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Because of failure to separate pharmacy from medical
practice in Taiwan, few prescriptions are filled in commu-
nity pharmacies.1,2 Pharmacy technicians are not allowed
to fill prescriptions and many hospital pharmacists are
occupied by distributive work. Most patients get informa-
tion of their drugs mainly from the labeling on the drug
envelopes.2,3 Inappropriate use of medication and inade-
quate knowledge of drug therapy among the general pop-
ulation have long been problems.1,4 Based on the successful
experience of pharmacist-led patient education programs
in Western countries,5,6 the Bureau of Pharmaceutical Af-
fairs in the Department of Health in Taiwan sponsored the
national Community Education Program on Medication Use
(CEPMU) beginning in 2002. The CEPMU is a 5-year program
designed to transfer medication knowledge from pharma-
cists to the general public in community universities.
With support from the government, other medical pro-
fessions, and patient advocates, practice environment,
pharmacy education, and interactions among pharmacists,
patients, and other health practitioners have been consid-
erably improved in the past few years in Taiwan. The 5-year
CEPMUwas oneof themost critical contributing factors for all
these encouraging changes. A studybetween September 2003
and January 2004 revealed that CEPMU improved the short-
termmedication knowledge of participants and led to greater
appreciation of the role of pharmacists as knowledge
workers.1,2 In 2005, efforts were made to improve the cour-
ses, teaching materials, and assessment tools and methods.
After the improvements, a studywas conducted to determine
the effects of CEPMU. Different from previous studies, this
study not only assessed knowledge improvement of the par-
ticipants but also identified areas where the general public
did not have adequate knowledge in medication use.
Prior to 2000, there was sparse research on the medical
knowledge of the general public in Taiwan.7 The limited
local studies showed that the general population required
assistance from health practitioners to make good use of
medical resources for better health.8,9 Most of the studies
focused on patients with specific diseases or conditions
(e.g., diabetes, asthma, pain control) and their families to
improve the knowledge on disease managements and self-
care.10e13 Although there were some health education
programs at the community level, all of them were either
held in a small scale and in restricted areas or were
implemented as one-time training only.7,8 Different from
previous studies, CEPMU targeted on the public populationto delivery general health care information when self-care
was warranted. A preliminary evaluation of the program in
2003e2004 indicated that the general public did not have
sufficient knowledge in self-care of health conditions,
sources of obtaining drug information, or patient rights in
the National Health Insurance in Taiwan.1 Subsequently, we
modified the contents of courses and questionnaire to
adjust the program to better meet the needs of the public.
The primary objective of this study was to determine
how much the participants knowledge had improved by
doing the national community education program over the
4-month semester. A secondary objective was to identify
the educational needs of adults related to medications.
Methods
Setting
The community university system is a nonformal educa-
tional institution for adults, under the supervision and
subsidization of local governments with the goal of lifelong
learning.14 The community universities usually locate in
schools that can be easily accessed by public trans-
portation. Currently, there are 83 community universities in
Taiwan, and 57 of them collaborated with the Department
of Health to provide CEPMU for the public. There is no
known difference between the community universities that
did and did not participate in the CEPMU program.
Furthermore, to reduce the disparity between rural and
urban areas, the CEPMU was offered in at least one com-
munity university in each rural or urban county.
Study design
This was a single-group pre- and post-program comparative
study. A questionnaire was administered twice every se-
mester: prior to the first lecture and again at the end of the
4-month program. Although an institutional review board
approval was not required by our regulations, the ques-
tionnaire clearly stated the purpose of the study, and the
participants answered the questions and signed their name
of their own free will.
Participants
No formal qualifications were required to enter this pro-
gram other than being older than 18 years old. Those who
Table 2 Lectures in the Community Education Program on
Medication Use.
No. Titles of the lectures
1a Medication-related regulations
2a General information about the use of medications
3 History of drug development and pharmaceutical
service
4a Dosage forms and how drugs produce effects
5a Proper use of drug information sources and
understanding package inserts and labeling
6a Drug interactions, adverse effects, and quality of drug
products
7a Precautions in using drugs in pregnant women,
children, and the elderly
8 Pediatric immunization and influenza vaccines
9a Over-the-counter drugs (I): antipyretics, antiemotion-
sickness, and the common cold
10a Over-the-counter drugs (II): gastrointestinal,
antidiarrheal, laxative, and dermatologic drugs
11 Self-care in gynecologic hygiene
12 Medications for chronic diseases: hypertension,
hyperlipidemias, and diabetes
13 Medications for hepatitis and asthma
14 Self-care for menopausal syndrome and benign
prostate hyperplasia
15 Weight control products and medical cosmetics
16 Dietary supplements: products, related regulations,
and advertisements
17 Chinese herbal medicine
18 Drug abuse
a Required lecture that all participants had to join during the
program.
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questionnaires with complete demographic data were
included in this study (Table 1). People who only completed
either the pre- or post-test questionnaires were excluded.
Intervention
The CEPMU was initiated in September 2002 in the form of a
didactic lecture, and was available in every spring and fall
semester nationwide in community universities.1,2 Standard-
ized teaching materials (including a paperback book and
PowerPoint slides) designed by senior pharmacy practitioners
and clinical faculty members from several universities were
revised and updated annually according to the response of
pharmacists and participants. Candidates for pharmacist
lecturers of CEPMU were recommended by hospitals or phar-
macists associations, and were then evaluated by a panel of
pharmacy experts based on a 5-minute teaching demonstra-
tion. Pharmacists that passed the evaluation participated in a
2-day workshop to familiarize them with the teaching mate-
rials and to provide them with standardized teaching skills.
In 2005, some redundant sections were merged and other
sections were rearranged or divided into more lectures. This
third edition expanded the number of lectures from 14 to 18
to cover medication use, the rights of patients, regulations,
and policies related to medication use (Table 2). Lectures
were divided into two groups: eight lectures were required
and ten lectures were elective. In addition to required lec-
tures, each community university chose from six to eight
elective lectures according to participants’ needs and
preferences. Each lecture consisted of a 3-hour learning
course, delivered with the aid of standardized slides. A
handout in the form of learning manual to help recall in-
formation learned in the class was also provided.
Instruments
In 2005, the questionnaire was modified according to the
results of the previous study1 to contain 50 true/falseTable 1 Background characteristics of the study partici-
pants (n Z 848).
Characteristics Number (%)
Sex
Male 214 (25.2)
Female 634 (74.8)
Age (y)
 30 81 (9.6)
31e40 120 (14.2)
41e50 225 (26.5)
51e60 296 (34.9)
61e70 95 (11.2)
 71 31 (3.7)
Highest education
Uneducated 5 (0.6)
Primary school 74 (8.7)
Secondary school 101 (11.9)
High school 319 (37.6)
University 328 (38.7)
Graduate school 21 (2.5)questions that could be divided into nine categories (Table
3). The instrument in the present study contained questions
using information from a drug package, a drug envelope,
and a prescription in order to assess how well the infor-
mation was understood by the public. The questionnaire
was designed according to the required lectures and to
emphasize common sense of medication use in daily life,
such as taking drugs during pregnancy, prescription refill,
over-the-counter drugs, etc. (Appendix 1). It also served as
an instrument to identify the educational needs of adults
related to medications.
To ensure the questionnaire’s content validity, a pre-
liminary version was revised by experts in pharmacy edu-
cation and pharmacy practice using a 5-category (1e5)
Likert scale and open-ended comments. A content validity
coefficient based on the Aiken formula was used to eval-
uate the revised questionnaire after incorporating the
suggestions from the experts.15 In addition, we recruited 51
volunteers to ensure the comprehensibility, appropriate
language level, relevance, and acceptability of the ques-
tionnaire for participants. The KudereRichardson 20 (KR-
20) coefficient and testeretest coefficient were used to
test for reliability.16 To minimize the potential bias from
memory effect on the testeretest reliability, there was an
interval of 2 weeks between the first and the repeated
questionnaires. After the input of pharmacy experts and a
pilot study using 51 participants, the final version of the
Table 3 Comparison of mean scores of participants’ medication knowledge in each category (n Z 848).a
Questionnaire
categorya
Full
score
Score Difference
in scorea,*
Average
improvement (%)Pre-test Post-test
Proper use of drug information 3 2.7  0.6 2.8  0.5 0.1  0.6 4.4
Understanding label on the drug envelope 7 5.7  1.2 6.1  1.0 0.4  1.2 5.4
Understanding drug package labeling 5 4.0  0.9 4.5  0.8 0.5  1.0 9.2
Health insurance system and self-care 6 4.5  1.0 5.3  0.8 0.8  1.1 13.5
Precautions and principles of drug use in pregnant
women, children, and the elderly
8 5.7  1.5 6.9  1.2 1.1  1.6 14.2
Common misconceptions about drug products 3 2.1  0.7 2.4  0.7 0.3  0.9 9.2
Principles of the use of over-the-counter drugs 10 6.8  1.7 8.1  1.6 1.3  1.9 12.5
Concepts in drug storage 3 2.0  0.8 2.5  0.7 0.6  0.9 18.3
Understanding chronic-disease refill prescription 5 3.2  1.1 3.9  1.0 0.7  1.3 13.5
Total 50 36.8 ± 5.8 42.5 ± 5.4 5.7 ± 6.0 11.3
Data are presented as mean  SD unless otherwise indicated.
*p < 0.001 by paired t test.
a Questionnaire divided into nine categories was administered twice in this program: prior to the first lecture and again at the end of
the 4-month program.
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and testeretest reliability coefficient of 0.86. The final
questionnaire distributed to all of CEPMU participants in
2005 and 2006 achieved a KR-20 reliability score of 0.75.
The instrument was valid and reliable.
Data collection and analysis
The total score of the questionnaire ranged from zero to 50,
and the difference between the pre- and post-test scores
for each participant was defined as the difference in score.
All of the variables were expressed as the mean  standard
deviation (SD). Demographic variables that might have
affected the baseline knowledge and outcome of learning
were also analyzed. A parametric method, the paired t test
for two related variables, was used to determine differ-
ences in self-comparison.
Due to the potential nesting effect from the hierarchical
nature of students clustered in schools, generalized linear-
mixed models were used to analyze the data. The final two
modelswerefit to test theeffects of participants’ characters,
such as age, sex, and education level on program outcome
after adjusting for potential confounders of school effects.
The primary model examined the relationships between the
demographic variables and baseline knowledge. The same
final model was used to further examine the relationship
between the demographic variables and the difference be-
tween participants in pre-to-post test scores. Sex was coded
as a dichotomous indicator (female student was set as
reference); age and education level (transformed into years
of education) were coded as continuous indicators.
Specific areas of medication knowledge deficiency were
discussed in order of each category (Table 3).
Item analysis
The results of the student performance evaluated by the
questionnaire were used to analyze the item difficulty
index and pre-to-post difference index (PPDI) of each true/
false item.17,18 Students were ranked based on number ofitems they answered correctly. The bottom quartile was
considered as low achievers and the top quartile as high
achievers. The item difficulty index was calculated based
on the percentages of the correct responders to each test
item, with the formula:
PZðPH þ PLÞ=2; ½1
where P was the item difficulty index, PH and PL were the
percentage of the students answering the item correctly in
the high achieving group and in the low achieving group,
respectively.17 An item was considered as difficult when the
difficulty index value was < 30% and considered as easy
when the index was > 70%, while a value between 30% and
70% was deemed appropriate in difficulty level.17 The PPDI
measured the differences of item difficulty index between
the pre- and post-test after an instructional intervention.
The PPDI was calculated using the formula:
PPDIZPpost  Ppre; ½2
where Ppost and Ppre were the item difficulty index of post-
and pre-test of the same item respectively. A PPDI >
0 indicated the effectiveness of an instructional program.18
A two-sided p < 0.05 was considered to be statistically
significant. All the statistical analyses were carried out
using SPSS version 18 (SPSS Inc., Chicago, IL, USA).
Results
Background characteristics of the participants
There were 1983 community residents enrolled in the
CEPMU at 57 community universities. Approximately 42.8%
(nZ 848) of the participating students completed the pre-
to-post questionnaire with complete demographic vari-
ables, including 214 males and 634 females with ages
ranging from 21 years to 82 years (mean  SD: 49.0  12.0
years). Approximately 8.7% of the 848 students had only
finished the 6-year elementary school, whereas 41.2% were
graduates of university or graduate school (Table 1).
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The average baseline knowledge score of the 848 participants
was 36.8  5.8 (mean  SD). Prior to the program, the par-
ticipants got the highest correctness rates in the category
“Proper use of drug information” (90.0%) and the lowest
correctness rates in the category “Understanding chronic-
disease refill prescription” (64.6%). A paired t test showed
significant improvement in both the individual nine category
scores and total post-test scores (post-test total score:
mean SDZ 42.5 5.4;p< 0.001; Table 3). At theend of the
program, the average improvement inmedication knowledge
was 11.3% (average score improvement: mean  SD Z
5.7  6.0), with the greatest improvement in the category
“Concepts indrug storage” (18.3%)andthe least improvement
in “Proper use of drug information” (4.4%; Table 3).
Determinants of knowledge level and improvement
The initial generalized linearemixed model showed that
the “school” variable has significantly affected the partic-
ipants performance in their pre-test scores and the score
improvement of pre-to-post test scores (p < 0.001). Our
final model is described as Table 4.
A generalized linear mixed model using the pre-test
score of the 848 participants showed that those who had
higher education level and were younger had better per-
formance in the pre-test baseline knowledge evaluation
(p < 0.001; Table 4).
The other generalized linear mixed model revealed that
the means of score improvement of pre-to-post test scores in
differentcommunityuniversitiesweresignificantly influenced
by the participants’ age (p Z 0.015) and years of education
(pZ 0.003; Table 4). Those who were younger and had lower
education level achievedmore improvement from theCEPMU.
Deficiency of the medication knowledge of the
participants
Prior to starting the program, many participants lacked basic
knowledge in several aspects of medication use (Table 3). ForTable 4 Generalized linear mixed model examining the
effects of participants’ characteristics on medication use
knowledge pre-test scores and difference of pre-to-post
test scores (n Z 848).
Variable Regression
coefficient
Standard
error
p
The effects of participants’ characteristics on medication
use knowledge pre-test scores
Intercept 32.751 1.531 < 0.001
Sex 0.742 0.440 0.092
Age 0.057 0.018 0.001
Years of education 0.489 0.063 < 0.001
The effects of participants’ characteristics on difference
of pre-to-post medication use knowledge test scores
Intercept 5.962 1.613 < 0.001
Sex 0.173 0.443 0.696
Age 0.044 0.018 0.015
Years of education 0.189 0.064 0.003example,many did not understand the instructions on chronic
refill prescriptions and had misconceptions regarding drug
storage, the health insurance system, drug use for special
populations, and over-the-counter drugs. In these areas, the
greatest improvement was observed following the program.
Item analysis
Prior to the program, 58% of the 50 true/false question
items had an item difficulty index of > 70%, and 40% and 2%
of the items had an item difficulty index of 30e70% and <
30%, respectively (Table 5). However, after the education
intervention, 82% of the items had an item difficulty index
of > 70%, and 18% of the items had an item difficulty index
of 30e70% (Table 5). Because 98% of the 50 true/false
question items had PPDI  0, the education program
intervention was deemed effective (Table 5). The PPDI was
shown to be correlated negatively with pre-test item dif-
ficulty index (r Z 0.89, p < 0.01).
Discussion
Evaluation of medication knowledge improvement
The results that pharmacist-led community education
improved the public medication knowledge by 11.3% at the
end of a semester indicated that participants retained a
limited amount of medication related information over a 4-
monthperiod (Table3). It also identified importantmedication
knowledge that health education should focuson in the future.
The demographics of the participants in this study are
similar to those of the participants in the previous study.1
Although the instrument used in this study is different
from that in the previous study, both studies revealed that
baseline medication knowledge was significantly correlated
with age and education level (Table 4).1
In this study, the average improvement in medication
knowledge was 11.3%, which is lower than the 23.6%
improvement recorded in our previous study.1 The deficiency
in knowledge retention is an indication that the CEPMU
program alone is not enough to improve the medication use
to the society. One-shot education appears successful from
immediate post-tests but the learners’ knowledge retention
is mostly lost over days and weeks, according to a study on a
diabetes patient education program.19 This is probably the
reason for the long-term effects of CEPMU in improving
medication knowledge being less significant than the short-
term effects as evaluated in a previous study.1 In this pro-
gram, it was anticipated that the proper use of the handout
may improve knowledge retention over extended time pe-
riods. Reinforcement is one of the best ways to retain
knowledge.20 Repeated efforts and multimedia are needed,
and knowledge is best delivered at the time of need (e.g.,
when a person is sick and required to take medicines).21
Deficiency of the medication knowledge of the
participants
This study also aimed to identify the areas upon which a
medication education program for the general public in
Table 5 Characteristics of the study participants (n Z 848).
Question Pre-test difficulty index Post-test difficulty index Pre-to-post difference index Categorya
1 0.96 0.97 0.01 A
2 0.75 0.84 0.09 A
3 0.43 0.65 0.22 A
4 0.84 0.91 0.07 A
5 0.91 0.94 0.04 A
6 0.95 0.97 0.02 B
7 0.92 0.96 0.04 B
8 0.42 0.59 0.17 B
9 0.95 0.95 0.00 B
10 0.72 0.80 0.08 B
11 0.78 0.84 0.06 B
12 0.81 0.85 0.04 B
13 0.80 0.85 0.05 C
14 0.33 0.53 0.20 C
15 0.63 0.86 0.23 C
16 0.59 0.76 0.17 C
17 0.83 0.90 0.08 C
18 0.58 0.69 0.11 E
19 0.97 0.98 0.01 G
20 0.43 0.63 0.20 E
21 0.88 0.93 0.05 F
22 0.90 0.95 0.05 H
23 0.37 0.70 0.09 I
24 0.76 0.97 0.07 E
25 0.54 0.71 0.34 F
26 0.76 0.82 0.07 E
27 0.54 0.73 0.20 G
28 0.67 0.77 0.10 E
29 0.86 0.91 0.05 H
30 0.60 0.82 0.21 G
31 0.93 0.96 0.03 E
32 0.84 0.91 0.07 H
33 0.91 0.95 0.04 E
34 0.69 0.85 0.15 F
35 0.74 0.91 0.17 D
36 0.78 0.86 0.08 G
37 0.91 0.97 0.06 E
38 0.60 0.84 0.24 G
39 0.86 0.97 0.10 D
40 0.67 0.80 0.12 D
41 0.43 0.64 0.21 D
42 0.24 0.55 0.30 E
43 0.98 0.99 0.01 G
44 0.93 0.97 0.04 D
45 0.50 0.80 0.30 D
46 0.63 0.81 0.18 I
47 0.90 0.94 0.04 I
48 0.54 0.73 0.19 D
49 0.91 0.97 0.06 D
50 0.42 0.57 0.15 E
a Questionnaire was divided in to nine categories: A Z Understanding drug package labeling; BZ Understanding label on the drug
envelope; CZ Understanding chronic-disease refill prescription; D Z Precautions and principles of drug use in pregnant women, chil-
dren, and the elderly; EZ Principles of the use of over-the-counter drugs; FZ Concepts in drug storage; GZ Health insurance system
and self-care; HZ Proper use of drug information; and IZ Common misconceptions about drug products.
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of the participants understood part of the information on
the drug package and envelope, such as the drug’s name,
usage, expiration date, and quantity. However, < 40% of
participants could identify the manufacturer of a drug by
referring to the drug license on the package, or locate the
indications listed on the drug envelope. Patients may
misinterpret drug label instructions if they are not well
educated or counseled, which could adversely impact on
patients.22 In dispensing drugs to patients, it is important
that pharmacists inform the patients on the indications
pertaining to the specific drugs, especially to those who are
elderly or with lower literacy.23
Furthermore, we found that approximately 50% of the
participants did not know the number refills that were
allowed for medications of chronic diseases nor did they
realize that prescriptions could be refilled in National
Health Insurance-contracted community pharmacies other
than the original prescribing hospitals or clinics. It is
important that pharmacists remind patients about the
number of refills and locations to refill a prescription for
chronic diseases.
About half of the participants thought that women
should stop all medications once they were pregnant and
that all tablets could be pulverized for children or elderly
use. Through our program, participants learned that some
tablets could not be chewed or crushed and liquid dosage
forms were more suitable for children. We also emphasized
that women with chronic diseases should not stop their
medications without first consulting their physicians or
pharmacists. Women who are pregnant or expect to get
pregnant should also be counseled for medications with
potential fetal or neonatal toxicity.
In the pre-test for “Principle of the use of over-the-
counter drugs” and “Concepts in drug storage,” > 70% of
the participants were correct about methods of drug stor-
age and self-care, including the function of drugs for
common cold, antivertigo drugs for carsickness, fluid and
electrolyte supplements for diarrhea, the sequence to use
ophthalmic drops and ointment, and the fact that glass
bottles are better than plastic bags for drug storage and
antitussives are not suitable for productive coughing.
However, approximately 60% of participants thought that
drugs for the common cold could kill bacteria, antacid
could prevent drug-related ulcers, laxatives were for mild
diarrhea, and refrigeration could protect drugs from hu-
midity. After pre-test evaluation, pharmacists in the CEPMU
program emphasized such misconceptions and achieved an
approximately 20% improvement in post-test evaluation. In
the categories “Health insurance system and self-care,”
“Proper use of drug information,” and “Common mis-
conceptions about drug products,” we found that partici-
pants were unfamiliar with services (e.g., Pap smear for
women older than 30 years) provided by the National
Health Insurance or the requirement of out-of-pocket
payment for designated doctors.
Pharmacists should be educated to address the most
deficient areas of the patients, so that they can effectively
allocate their limited time to achieve better outcome. The
results of this study have helped to improve the follow-up
medication education programs in the communities. Other
improvements (such as changing the design and wording ofdrug labels) have been made after some deficiencies were
identified through CEPMU.
Evaluation of the program and questionnaire
PPDI can be used as an indicator to evaluate instructional
effectiveness of an educational program.18 In our study, the
item difficulty index of 24% of the question items changed
from medium difficulty prior to the program to the level of
easy after the program, and 98% of the question items had a
positive PPDI after the program. It showed that the par-
ticipants had improved medication knowledge after
receiving the education program.
Similar to our previous evaluation on CEPMU, the present
study demonstrated that pharmacist-led service is associ-
ated with significant and positive changes in patient
knowledge extension and retention. These findings affirm
the benefit for pharmacists to play an important role in
patient education.
Limitations
Theparticipants’ demographicdata in this studyare similar to
the students in other community university courses (75% fe-
male; mean age, 50 years old) but are somewhat different
fromthoseof thegeneral population.14 Extrapolationof these
results to general populations in Taiwan may be limited.
Due to the limitation of the study design, there was no
matched control group or randomization in this study. It is
possible that all of the threats to validity that could influ-
ence studies with such a single-group pre- and post-
comparison (e.g., test, maturation, and history) might
have affected the study results. However, we have taken
some approaches to reduce the threats. For example, to
minimize the memory effect of repeated testing, we
administrated the two tests at a 14-week interval. The
study duration was short, so maturation might not be an
important factor; in addition, there was no other large
educational intervention taking place during the short
study period, so history might not have a prevailing impact.
Even though we used standardized materials and trained
the pharmacists to provide standardized contents, the
variable of school effects remained a significant factor on
the performance of the participants. According to the re-
sults from the regression model, there was still a significant
portion of unaccountable variance in the study outcome,
which suggests the existence of other factors that could
affect the outcome but have not been captured in the
current study. For example, income, motivation and per-
sonality might be important in influencing the performance
but have not been captured by the basic demographic data
(age, education status, and sex) in the current study.
The limited number of questions for nine categories and
the potential ceiling effect of the test may be the other
concern. Both could jeopardize the ability of the ques-
tionnaire to detect a true difference in scores. Moreover,
the magnitude of improvement at post-test evaluation
might also have been limited by the fact that most of the
items in the questionnaire had a higher difficulty index in
the beginning. Although the ceiling effect may prevent
some high-score participants from benefiting as much as
1274 Y.-M. Huang et al.other participants, it might be acceptable for two reasons:
the program is aimed to deliver the most relevant health-
related information to the general public and the program
can serve as a refresher course to reinforce knowledge to
high-score achievers. This study provides us with a pilot
model to tailor a more complete health education program
for the public in the future. We can emphasize other
relevant topics that the public are unfamiliar with and
should focus on those who have a lower education level to
enhance their knowledge to help them self-care.Conclusion
The results of this study indicated that members of the
general public increase a limited amount of medication
related information over a 4-month period. Patient coun-
seling focusing more on the knowledge deficiency identified
in this study during patient care is recommended. Knowl-
edge areas that required further improvement included the
understanding of instructions on refilling prescriptions for
chronic conditions, proper storage of medication, the
health insurance system, drug use in special populations,
and over-the-counter drugs.Panadol® film-co
10 Caplets Aspirin-free, won
Indication: fever, pain (mild-to-moderate pain, 
muscle pain, sprains, back pain, dysm
pain, and toothaches)
Ingredients: Each tablet contains acetaminophen
Dosage: one tablet for adults, not to exceed fou
License number: DOHIMP123456
Expiration date: 2 years
Caution:
1. Keep out of the reach of children.
2. Read the package insert before taking
3. Store in a cool and dry place.
Doctor- and pharmacist-indicated drug.Acknowledgments
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Appendix 1
Please answer the following true/false questions.I. There are three classes of drugs: over-the-
counter drugs, pharmacy medications, and
prescription drugs. Please answer Questions 1e5
according to the information on the package of the
pharmacy medicine listed below.ated caplets
Pa
na
do
l®
M
fg
. D
at
e 
   
Lo
t N
o.
20
04
  0
1
A
B
C
D
12
E
’t irritate stomach.
such as headaches, 
enorrhea, minor joint 
 500 mg
r times per day
 this drug.
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2. The maximum dose of the drug is 500 mg per day.
3. The drug is made domestically.
4. The expiration date of the drug is January 2006.
5. There are 20 tablets per pack.X, XX Street, XX District, Taipei
Dispensing Date: 01/01/2005
Prescription No.: A-1234
Name: Tom Lee
Route: Oral
Dose and Frequency: Twice daily; One tablet
Drug name:
NACID 500 MG/T
(HYDROTALCITE 500 MG TABLET)
Duration:    
Description of the tablet: white, round, diame
Special instructions: chew the tablet before sw
Clinical use: antacid
Possible adverse effect: unpleasant taste, diar
Department: Orthopedics
Doctor: Tiger Wang
Please check patient name on the bag and qua
Please read the other instructions on the reve
if you have any questions.
National XXXX HospitalII. Mr. Lee visited a doctor due to pain in his hands.
Below is one of the bags of a drug prescribed for
him by a doctor. Please answer Questions 6e12.
Front of medication bagChart No.: 1234567
Account No.: 7654321
 a time
14   days
Quantity:    28   Tablets
ter: 15.1 mm
allowing it
rhea or constipation
Dispensing pharmacist: Flower 
Huang
Verification pharmacist: Pearl 
Chang
ntity of the drug.
rse side of the bag. Ask the pharmacists 
1276 Y.-M. Huang et al.6. NACID is 寧適錠.
7. The drug should be taken three times a day.
8. This drug was used to relieve pain in Mr. Lee’s hands.
9. Mr. Lee should chew the tablet before swallowing it.
10. All the patients who take the drug will suffer from
diarrhea or constipation.
Reverse side of medication bagSpecial Instructions: 
1. Directions 
for use:
(1) At bedtime: half an hour
(2) On an empty stomach: 1
(3) After meals: take immed
(4) May take before or after
(5) Once daily: take at a fixe
(6) Twice daily: take in the 
(7) Three times daily: take i
evening
(8) Four times daily: take in
and at bedtime
2. Please keep the drug envelopes until all th
3. Beyond-use date: The beyond-use date is t
on the drug package or bag.
4. Storage conditions: Keep the medication in
expired or spoiled medication.
5. Counseling phone: (02)1234-5678
6. Hospital website: http://www.health.edu.tw11. Mr. Lee took the drug at 9:00AM on January 2, 2005. He
should take next dose at 9:00AM on January 3, 2005.
12. There was no beyond-use date on the bag or package.
Mr. Lee should discard the drug no later than March 1,
2005. before bedtime
 hour before or 2 hours after a meal
iately after foods
 meals if not otherwise indicated
d time daily
morning and evening
n the morning, at noon and in the 
 the morning, at noon, in the evening 
e medications are used.
hree months unless otherwise specified 
 a dry and cool place. Please discard 
Medication knowledge in community universities 1277III. Mr. Chang’s chronic disease was under control.
His physician prescribed a chronic-disease refill
prescription for him. Please answer Questions   Outpatient Chronic-Disease Refill Pre
Hospital code: 001
Name: Lion Chang
I.D.: A123456789
Department: Internal Med.
Diagnosis: 401.9
Birthday: 01/0
Hypertension
Drug name and dosage form Dosage
ATEOL F.C. 100 MG
(ATENOLOL 100 MG TAB)
PO 0.5 
TAB QD
The prescription can be filled twice.
Physician
Signature
First fill
Please have the prescription 
filled within 3 days
Stamp
Hospital
Stamp
Third fill
The prescription can be refille
after xx/xx/xx
Date
Account No.
Stamp13e17 according to the information on the
prescription below.scription
1/1955 Prescription Date: 01/01/2005
Prescription No.:0001
Chart No.: 1234567
Account No.: 7654321
Quantity NHI Code Duration
14 TAB A033029100 28 days
Page one
Second fill
The prescription can be refilled 
after 01/21/2005
Date
Account No.
Stamp
d 
1278 Y.-M. Huang et al.13. The quantity of medication in this chronic-disease
refill prescription is good for 14 days.
14. This chronic-disease refill prescription can be filled
three times.
15. This prescription can only be filled at the original
hospital or clinic where it was prescribed. It cannot
be filled at an National Health Insurance-contracted
community pharmacy.
16. The pharmacist can substitute the drug on the pre-
scription with another brand of the same ingredient.
17. After the first fill, the prescription can be filled again
after 01/21/2005.
IV. Please answer the following questions related to
medication use and health.
18. Drugs for the common cold can kill the bacteria that
cause common cold.
19. Non-therapeutic plastic surgery is covered by Na-
tional Health Insurance.
20. Antacids can prevent drug-induced ulcers.
21. It is better to store opened drugs in glass containers
than in plastic bags.
22. Medication counseling provided by pharmacists suits
personal needs better than information from news-
papers, magazines or the Internet.
23. Patients may stop symptom-relieving drugs, such as
those for headache or runny nose, once the symptoms
have stopped.
24. When using eye drops and ophthalmic ointment
concomitantly, patients should use the drops first and
ointment 5e10 minutes later.
25. Storing opened drugs in a refrigerator can protect
them from humidity.
26. Coughs with sputum should be treated with
antitussives.
27. The practice of a doctor running a pharmacy just next
to his or her clinic is the best model of “separation of
pharmacy from medical practice”.
28. Using commercialized wet tissue instead of water to
manage diaper rash can minimize skin irritation.
29. The practice that putting all drugs in a single bag
labeled with only the drug name is in line with the
regulations of the Department of Health in Taiwan.
30. Services provided by specially designated doctors,
especially registered nurses and senior registered
nurses, are not covered by National Health Insurance.
31. Antivertigo drugs should be taken when you feel sick
in the car.
32. If eye drops are re-packed into small plastic con-
tainers with no label, it may harm patients.
33. There is no elixir for colds. Generally, cold medicines
are intended to relieve patients’ symptoms, such as
cough, running nose, and fever.
34. Opened drugs are durable if frozen.
35. All oral tablets can be pulverized for children.
36. The expense of annual Pap smears for women older
than 30 years is covered by National Health
Insurance.
37. The primary therapy for diarrhea is to supplement
water and electrolytes rather than use anti-diarrhea
medication.38. In general, healthy adults must see a doctor once
they have an ailment such as a cold and runny nose.
39. Self-care is not suitable for pregnant women, senior
citizens, children younger than 2 years, and patients
with chronic diseases.
40. We may persuade children younger than 12 years to
take drugs by telling them that the drugs are
“candies”.
41. Women with chronic diseases (such as hyperthyroid-
ism) on long-term therapy must stop their medica-
tions once they are pregnant.
42. Laxatives are used to relieve mild diarrhea.
43. Prescription drugs can only be obtained with a doc-
tor’s prescription.
44. Some drugs will affect infants through breastfeeding.
Therefore, nursing mothers should stop breastfeeding
during and a certain period of time following drug
therapy.
45. For children younger than 12 years, commercialized
liquid formula provides more accurate dosage than
extemporaneously divided pulverized tablets.
46. Oral drugs can be dissolved in water and injected into
patients who are unable to take drugs orally.
47. Patients on hypertension, hyperglycemia, or diabetes
drug therapy can stop therapy once their blood
pressure, cholesterol, and blood sugar return to
normal levels.
48. If a child younger than 5 years accidentally ingests
erosive material, emesis should be induced
immediately.
49. Drug dosage should be individualized for the elderly
due to the deterioration of organ function with age.
50. It is better to clean the tips of eye drop or ointment
containers with tissue after use to keep these drugs
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